{"date":"2026-02-24","count":72,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6541-2026-02-24-2253-sjl8ul","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"22:53:25","subject":"公告本公司114年度合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-02-24 22:53，「公告本公司114年度合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-02-24-2235-uutmnv","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"22:35:51","subject":"公告本公司稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-02-24 22:35，「公告本公司稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-02-24-2231-fk86cc","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"22:31:14","subject":"本公司北加州廠接受美國FDA查廠之說明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-02-24 22:31，「本公司北加州廠接受美國FDA查廠之說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-02-24-2203-bwopfv","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"22:03:33","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-02-24 22:03，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-02-24-2202-10fn4ra","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"22:02:27","subject":"公告本公司董事會重大決議事項","clause":"第44款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-02-24 22:02，「公告本公司董事會重大決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-02-24-2200-1b89la1","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"22:00:52","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-02-24 22:00，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-02-24-2158-bhx8nz","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"21:58:44","subject":"公告本公司配合會計師事務所內部調整更換會計師","clause":"第7款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-02-24 21:58，「公告本公司配合會計師事務所內部調整更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2026-02-24-2157-1s7j09a","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"21:57:13","subject":"公告本公司董事會決議召開115年股東常會日期暨相關事宜","clause":"第32款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2026-02-24 21:57，「公告本公司董事會決議召開115年股東常會日期暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-24-2125-11b1948","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"21:25:52","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-24 21:25，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-24-2105-1el2evl","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"21:05:16","subject":"公告本公司董事會決議修訂114年度限制員工權利新股發行辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-24 21:05，「公告本公司董事會決議修訂114年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-02-24-2100-hkr4jp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"21:00:24","subject":"公告本公司擬增資100%子公司DesigneRx Pharmaceuticals, Inc.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-02-24 21:00，「公告本公司擬增資100%子公司DesigneRx Pharmaceuticals, Inc.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-02-24-2058-1mdr2e2","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"20:58:46","subject":"公告本公司董事會通過115年股東常會召開相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-02-24 20:58，「公告本公司董事會通過115年股東常會召開相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-24-2015-2int1w","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"20:15:20","subject":"公告本公司董事會決議113及114年度限制員工權利新股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-24 20:15，「公告本公司董事會決議113及114年度限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-24-1951-1gi0jw4","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"19:51:05","subject":"公告本公司董事會決議114年第4季不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-24 19:51，「公告本公司董事會決議114年第4季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-02-24-1919-1t6kaux","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"19:19:44","subject":"公告子公司中天(上海)生物科技有限公司與合一生技共同研發之小核酸新藥SNS851，獲澳洲人體試驗倫理審查委員會同意進行一期人體臨床試驗，並已獲澳洲藥物管理局備查。","clause":"第53款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-02-24 19:19，「公告子公司中天(上海)生物科技有限公司與合一生技共同研發之小核酸新藥SNS851，獲澳洲人體試驗倫理審查委員會同意進行一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-02-24-1854-85pn28","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"18:54:38","subject":"本公司與中天(上海)共同研發之小核酸新藥SNS851，獲澳洲人體試驗倫理審查委員會同意進行一期臨床試驗，並已獲澳洲藥物管理局備查。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-02-24 18:54，「本公司與中天(上海)共同研發之小核酸新藥SNS851，獲澳洲人體試驗倫理審查委員會同意進行一期臨床試驗，並已獲澳洲藥物管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-24-1853-5j9yh6","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"18:53:19","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-24 18:53，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-02-24-1847-11r8ft9","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"18:47:38","subject":"本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-02-24 18:47，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-02-24-1837-l7qirp","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"18:37:59","subject":"公告本公司會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-02-24 18:37，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-02-24-1830-1nir76t","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"18:30:02","subject":"本公司董事會決議無股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-02-24 18:30，「本公司董事會決議無股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-02-24-1750-194jtjo","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"17:50:41","subject":"公告本公司114年度個體暨合併財務報告預計提報董事會日期","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-02-24 17:50，「公告本公司114年度個體暨合併財務報告預計提報董事會日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-02-24-1745-a5wbsz","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"17:45:15","subject":"公告本公司於證券法規遵循輔導契約存續期間內終止委任證券承銷商","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-02-24 17:45，「公告本公司於證券法規遵循輔導契約存續期間內終止委任證券承銷商」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-02-24-1741-wv2wjh","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"17:41:55","subject":"公告本公司114年度第四季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-02-24 17:41，「公告本公司114年度第四季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-02-24-1737-1wbpy2a","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"17:37:28","subject":"公告本公司114年第4季財務報告董事會預計召開日期為115年3月4日","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-02-24 17:37，「公告本公司114年第4季財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-02-24-1724-1ckb0on","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"17:24:25","subject":"本公司114年度財務報告董事會預計召開日期為115年3月4日","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-02-24 17:24，「本公司114年度財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-02-24-1722-er72mo","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"17:22:38","subject":"公告本公司擬與德國Baxter Deutschland GmbH簽署「Manufacturing and Supply Agreement」合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-02-24 17:22，「公告本公司擬與德國Baxter Deutschland GmbH簽署「Manufacturing and Supply 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-02-24-1721-7vlfa1","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"17:21:30","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月4日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-02-24 17:21，「公告本公司114年度財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-02-24-1711-dw08n8","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"17:11:40","subject":"董事會決議股利分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-02-24 17:11，「董事會決議股利分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-02-24-1711-1heyrik","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"17:11:27","subject":"公告本公司114年度個體暨合併財務報告董事會預計召開日期為115年3月5日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-02-24 17:11，「公告本公司114年度個體暨合併財務報告董事會預計召開日期為115年3月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-02-24-1707-1a21uy8","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"17:07:28","subject":"本公司受邀參加亞洲授權合作與精準療法高峰論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-02-24 17:07，「本公司受邀參加亞洲授權合作與精準療法高峰論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-24-1705-19sa9s9","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"17:05:18","subject":"公告董事會決議股利分派事宜","clause":"第14款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-24 17:05，「公告董事會決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-02-24-1659-gc9svd","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:59:13","subject":"代子公司APBIO PTY LTD公告研發中雙特異性抗體抗癌新藥AP601，於澳洲治療實體腫瘤第一期臨床試驗完成第一例受試者收案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-02-24 16:59，「代子公司APBIO PTY LTD公告研發中雙特異性抗體抗癌新藥AP601，於澳洲治療實體腫瘤第一期臨床試驗完成第一例受」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-02-24-1657-3qn6pb","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:57:52","subject":"公告本公司董事會決議114年度股利分派情形","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-02-24 16:57，「公告本公司董事會決議114年度股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-02-24-1657-11r8ft9","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:57:09","subject":"本公司董事會決議召開民國115年股東常會","clause":"第32款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-02-24 16:57，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-02-24-1655-1vss6kp","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:55:53","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分配案","clause":"第44款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-02-24 16:55，「公告本公司董事會通過114年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-02-24-1654-5j9yh6","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:54:28","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-02-24 16:54，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-24-1653-1dd9qx8","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"16:53:33","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-24 16:53，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-02-24-1649-6r4w23","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:49:58","subject":"公告本公司董事會決議115年股東常會相關事宜案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-02-24 16:49，「公告本公司董事會決議115年股東常會相關事宜案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-24-1649-nob2a5","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"16:49:37","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-24 16:49，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-24-1648-c6ibsk","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"16:48:48","subject":"公告本公司董事會通過設置永續長","clause":"第8款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-24 16:48，「公告本公司董事會通過設置永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-24-1647-zaw2nq","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"16:47:59","subject":"代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形","clause":"第51款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-24 16:47，「代子公司「江蘇生達生技醫藥有限公司」公告資金貸與超限改善計畫執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-02-24-1647-57zczs","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"16:47:06","subject":"公告董事會通過114年第四季合併財務報告","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-02-24 16:47，「公告董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-02-24-1642-fqsc9p","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:42:45","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-02-24 16:42，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-24-1641-1mvy42n","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:41:26","subject":"公告本公司董事會決議股利分派情形","clause":"第14款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-24 16:41，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-24-1638-1xu0c7w","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:38:56","subject":"公告本公司董事會決議115年股東常會召開事宜","clause":"第17款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-24 16:38，「公告本公司董事會決議115年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-24-1635-ucy9gy","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:35:12","subject":"公告本公司董事會通過113年現金增資之計畫總金額","clause":"第16款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-24 16:35，「公告本公司董事會通過113年現金增資之計畫總金額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-24-1634-ii8kf","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:34:55","subject":"公告本公司董事會決議解除經理人之競業禁止限制","clause":"第21款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-24 16:34，「公告本公司董事會決議解除經理人之競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-02-24-1634-1lcce0o","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:34:46","subject":"更正本公司114年12月營收公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-02-24 16:34，「更正本公司114年12月營收公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-24-1634-1iy3w5g","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:34:37","subject":"公告本公司董事會決議通過114年度員工酬勞及董事酬勞","clause":"第53款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-24 16:34，「公告本公司董事會決議通過114年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-02-24-1634-5j9yh6","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:34:16","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-02-24 16:34，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-02-24-1631-1ctgck9","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:31:49","subject":"本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-02-24 16:31，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-02-24-1626-n46xd","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:26:14","subject":"公告本公司接獲主辦證券承銷商辭任事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-02-24 16:26，「公告本公司接獲主辦證券承銷商辭任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-02-24-1625-pvmjct","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:25:07","subject":"代子公司芮弗士醫事檢驗所公告向關係人租賃取得不動產使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-02-24 16:25，「代子公司芮弗士醫事檢驗所公告向關係人租賃取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-02-24-1624-9zluly","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-02-24","time":"16:24:11","subject":"本公司董事會決議通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-02-24 16:24，「本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-02-24-1614-92x690","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:14:46","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-02-24 16:14，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-02-24-1614-w86bh0","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:14:18","subject":"公告本公司董事會通過115年對「財團法人研揚文教基金會」之捐贈","clause":"第43款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-02-24 16:14，「公告本公司董事會通過115年對「財團法人研揚文教基金會」之捐贈」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-02-24-1613-fqsc9p","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:13:55","subject":"本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-02-24 16:13，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-02-24-1613-ypvguv","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:13:31","subject":"董事會決議通過114年度員工酬勞及董事酬勞分配案","clause":"第53款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-02-24 16:13，「董事會決議通過114年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-02-24-1612-1sxywti","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:12:31","subject":"公告本公司董事會通過114年度合併財務報告案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-02-24 16:12，「公告本公司董事會通過114年度合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-02-24-1611-1lnvtez","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:11:56","subject":"本公司提報董事會114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-02-24 16:11，「本公司提報董事會114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-02-24-1611-6y5xdu","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:11:34","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-02-24 16:11，「公告本公司董事會通過114年度員工酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-02-24-1609-eo5xzz","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"16:09:46","subject":"公告本公司114年度自結個體及合併財務報告董事會預計召開日期為115年03月04日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-02-24 16:09，「公告本公司114年度自結個體及合併財務報告董事會預計召開日期為115年03月04日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-02-24-1603-ein36c","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:03:23","subject":"公告本公司董事會追認修訂一一四年度員工認股權憑證發行及認股辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-02-24 16:03，「公告本公司董事會追認修訂一一四年度員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-02-24-1601-109jtcw","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"16:01:09","subject":"本公司受邀參加元大證券舉辦之線上法說會","clause":"第12款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-02-24 16:01，「本公司受邀參加元大證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-02-24-1559-5vxs0m","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"15:59:39","subject":"公告本公司董事會辦理私募普通股案相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-02-24 15:59，「公告本公司董事會辦理私募普通股案相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-02-24-1554-1r1w2m4","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"15:54:22","subject":"本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-02-24 15:54，「本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-02-24-1520-7vlfa1","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"15:20:14","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月4日","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-02-24 15:20，「公告本公司114年度財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-02-24-1505-1xvpht","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"15:05:42","subject":"本公司董事會議決議召開115年股東常會公告(更正召集事由)","clause":"第17款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-02-24 15:05，「本公司董事會議決議召開115年股東常會公告(更正召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-02-24-1431-7vlfa1","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-02-24","time":"14:31:42","subject":"公告本公司114年度財務報告董事會預計召開日期為115年3月4日","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-02-24 14:31，「公告本公司114年度財務報告董事會預計召開日期為115年3月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-02-24-1423-2iz4hx","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"14:23:40","subject":"公告本公司董事會決議不發放股利","clause":"第14款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-02-24 14:23，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-02-24-1416-nbewbj","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"14:16:01","subject":"本公司董事會議決議召開115年股東常會公告","clause":"第17款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-02-24 14:16，「本公司董事會議決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-02-24-1407-1nb8hvk","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-02-24","time":"14:07:52","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第31款","fact_date":"2026-02-24","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-02-24 14:07，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}